Day One Biopharmaceuticals, Inc.

NASDAQ:DAWN

12.79 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income 37.037-4.407-62.412-54.511-46.15-45.863-42.393-40.109-37.795-36.53-27.747-21.938-19.241-15.474-16.101-35.6-3.842-2.408-1.993
Depreciation & Amortization 0.7460.4080.1160.1030.0990.0920.0890.180.1650.1330.0530.0510.050.0490.0490.0490.0460.0460.014
Deferred Income Tax 00041.576-45.7944.218000000000-0.5780.270.090.218
Stock Based Compensation 11.55413.0312.64410.8119.6069.4779.4476.8338.5765.6316.2025.0975.1492.5370.5380.350.060.0570.059
Change In Working Capital -52.20750.7371.2153.801-0.975-0.8797.471-1.2156.8710.979-0.0713.641.816-0.525-2.236-0.167-0.1210.317-0.386
Accounts Receivables 0.441-9.13600000000000000000
Change In Inventory -2.554-0.12900000000000000000
Change In Accounts Payables -3.4271.6642.204-0.815-1.174-0.0744.379-3.7133.534-0.262-1.0431.0590.338-0.3390.484-0.1710.1480.1120.043
Other Working Capital -46.66758.338-0.9894.6160.199-0.8053.0922.4983.3371.2410.9722.5811.478-0.186-2.720.004-0.2690.205-0.429
Other Non Cash Items 53.623-96.7159.38-43.15246.15-9.477-0.599-0.999-1.031-0.2620-0.0190.0050.0078.00730.0080.0090.010.003
Operating Cash Flow 50.753-49.129-49.729-41.372-37.064-42.432-25.985-35.31-23.214-29.787-21.563-13.169-12.221-13.406-9.743-5.938-3.578-1.888-2.085
Investing Activities:
Investments In Property Plant And Equipment -0.724-17.1260-0.008-3.041-0.149-0.0260-0.004-0.007-0.015800-80.0010-0.005-0.088
Acquisitions Net 000-2.9913-0.020.0110-200000000000
Purchases Of Investments -214.634-121.599-47.162-99.137-79.957-104.73-160.014-121.368-266.848-5.99000000000
Sales Maturities Of Investments 202.65947.782136.45129.525171.915125.153148.847119.158200000000000
Other Investing Activites -5510889.2882.991-30.02-0.011-0.00220-5.990-80000000
Investing Cash Flow -67.69917.05789.28830.3888.91720.274-11.193-2.21-246.852-5.997-0.015800-80.0010-0.005-0.088
Financing Activities:
Debt Repayment 0000000000000000000
Common Stock Issued 178.1771.2970.0480.5970.115162.1011.1841.9182.05300167.66-0.615000000
Common Stock Repurchased 0001.2500000000.3180000000
Dividends Paid 0000000000000000000
Other Financing Activities 21.9181.2970.0480.5970.115162.1011.1841.9182.053161.9300.3180168.532128.88529.977000
Financing Cash Flow 200.0951.2970.0480.5970.115162.1011.1841.9182.053161.9300.318-0.615168.532128.88529.977000
Other Information:
Effect Of Forex Changes On Cash 000228.584-98.118-130.46600000-80000000
Net Change In Cash 183.149-30.77539.607-10.39551.968139.943-35.994-35.602-268.013126.146-21.578-12.851-12.836155.126111.14224.04-3.578-1.893-2.173
Cash At End Of Period 422.765239.616270.391230.784241.179189.21149.26885.262120.864388.877262.731284.309297.16309.996154.8743.72819.68823.26625.159